Chromocell Therapeutics Corp's total assets for Q3 2024 were $2.14M, a decrease of -17.81% from the previous quarter. CHRO total liabilities were $3.57M for the fiscal quarter, a 28.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.